Roche tMate

Roche tMate

by F. Hoffmann-La Roche

3 ratings

Archived App (Last seen on 23 Jul 2026)

This is an archived listing of the app previously available on the App Store.

Although the app is no longer distributed by Apple, you can still view its description, screenshots, version history, ratings, and metadata for reference.
Rating summary
1
2
0
0
0

Details

  • Released
  • Updated
  • June 3, 2021
  • October 17, 2022

Features

Roche tMate screenshot #1 for iPhone
Roche tMate screenshot #2 for iPhone
Roche tMate screenshot #3 for iPhone
Roche tMate screenshot #4 for iPhone
🖼️Get Icon
Icons↘︎

About

This app facilitates communication and information sharing for clinical trial participants and sites. It helps manage schedules and reduces patient burden in Roche pRED clinical trials.

Schedule management
Information sharing
Communication tools
Patient engagement
Clinical site support
Show original description

What's New in Roche tMate

2.0.20

October 17, 2022

Added multi-lingual support for; German, Italian, Japanese, Dutch, Polish, Russian, Thai, Turkish, Ukrainian, Portuguese

Developer apps

FAQ

What is Roche tMate used for?

Roche tMate is a mobile app designed to reduce patient burden and improve engagement for participants and clinical sites involved in Roche pRED clinical trials. It supports functions like schedule management, information sharing, and communication.

Is Roche tMate free to use?

Yes, Roche tMate is available for free. It does not have any in-app purchases or advertisements.

What devices does Roche tMate support?

Roche tMate is supported on iPhone and iPod devices.

How often is Roche tMate updated?

The latest version of Roche tMate is 2.0.20, and it was last updated on October 17, 2022.

What is the age rating for Roche tMate?

Roche tMate has an age rating of 4+, making it suitable for a wide range of users.

What is the user rating for Roche tMate?

Roche tMate has a user rating of 4.3 stars based on 3 ratings.

Who developed Roche tMate?

Roche tMate was developed by Roche SAS.